Akihisa Oda
Kashihara-shi, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Maternal-fetal transfer of emicizumab in a pregnant mouse model.
Journal: Blood advances
Published: December 04, 2025
Generation of a Severe Hemophilia A Humanized Mouse Model Capable of Inducing an Anti-FVIII Immune Response.
Journal: Thrombosis and haemostasis
Published: April 29, 2025
The emicizumab-bridged ternary complex with activated factor IX and factor X evaluated by fluorescence resonance energy transfer.
Journal: Thrombosis research
Published: June 13, 2023
Angiopoietin-like 4 Is a Critical Regulator of Fibroblasts during Pulmonary Fibrosis Development.
Journal: American journal of respiratory cell and molecular biology
Published: May 16, 2023
The spleen is the major site for the development and expansion of inhibitor producing-cells in hemophilia A mice upon FVIII infusion developing high-titer inhibitor.
Journal: Thrombosis research
Published: October 25, 2022
Longitudinal profiling of anti-factor VIII antibodies in Japanese patients with congenital hemophilia A during factor VIII replacement and immune-tolerance induction therapy.
Journal: International journal of hematology
Published: February 09, 2022
Transcription factor Tlx1 marks a subset of lymphoid tissue organizer-like mesenchymal progenitor cells in the neonatal spleen.
Journal: Scientific reports
Published: September 09, 2019
Niche-induced extramedullary hematopoiesis in the spleen is regulated by the transcription factor Tlx1.
Journal: Scientific reports
Published: November 01, 2017
Last Updated: 09/26/2026